This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
See Cramer's multi-million dollar portfolio for FREE and get his new book Get Rich Carefully! Learn More

Regeneron Pharmaceuticals Inc. (REGN)

NASDAQ: Health Care

Get a 5-page Ratings Report on (REGN) now
$296.74-3.40 | -1.13%
04/17/14 - 4:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 2.10B 1.38B 445.82M 459.07M
Cost of Sales 114.15M 47.52M 4.22M 2.09M
Gross Operating Profit 1.99B 1.33B 441.61M 456.98M
Selling, General, and Administrative Expenses 329.42M 210.76M 117.26M 65.20M
Research & Development 859.95M 625.55M 529.51M 489.25M
Operating Income before D & A (EBITDA) 801.23M 494.65M -205.16M -97.47M
Depreciation & Amortization 41.20M 36.94M 31.08M 19.69M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -231.00K 2.01M 3.55M 2.12M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 759.80M 459.72M -232.69M -115.04M
Interest Expense 46.44M 45.30M 21.28M 9.12M
Pre-Tax Income 713.36M 414.42M -253.97M -124.16M
Income Taxes 289.00M -335.85M -1.13M 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 424.36M 750.27M -221.76M -104.47M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 424.36M 750.27M -221.76M -104.47M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 424.36M 750.27M -221.76M -104.47M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
424.36M 750.27M -221.76M -104.47M
Preferred Dividends
Net Income Available To Common 424.36M 750.27M -221.76M -104.47M
Basic EPS from Continuing Ops. 4.33 7.92 -2.45 -1.26
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 4.33 7.92 -2.45 -1.26
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 4.33 7.92 -2.45 -1.26
Basic Normalized Net Income/Share 4.33 7.92 -2.45 -1.26
EPS fr Continuing Ops. 3.81 6.50 -2.45 -1.26
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 3.81 6.50 -2.45 -1.26
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.25 0.00 0.00
EPS, Total 3.81 6.75 -2.45 -1.26
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
3.81 6.50 -2.45 -1.26
Dividends Paid per Share 0.00 0.00 0.00 0.00
(REGN) News

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
DOW 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 +2.54 0.14%
NASDAQ 4,095.5160 +9.2910 0.23%

Brokerage Partners

Top Rated Stocks Top Rated Funds Top Rated ETFs